Developing new cancer-fighting peptides from moroidin
Biosynthetic Development and Diversification of Moroidin Peptides for Cancer Applications
This study is working on developing new versions of moroidin peptides that could help treat cancer better, using special techniques to make more of these helpful substances from plants, which could lead to improved treatments for patients like you.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10994826 on NIH RePORTER |
What this research studies
This research focuses on creating and improving moroidin peptides, which are promising candidates for cancer treatment. By using advanced biosynthetic techniques, the team aims to produce a variety of moroidin analogs that could enhance their effectiveness against cancer cells. The approach involves engineering specific plant systems to maximize the production of these peptides, allowing for better availability and potential therapeutic applications. Patients may benefit from new, more effective cancer treatments derived from these innovative peptides.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who are seeking new treatment options.
Not a fit: Patients who are not currently undergoing cancer treatment or those with non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective cancer therapies.
How similar studies have performed: Other research has shown promise in developing peptide-based therapies for cancer, indicating that this approach could be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Shafiq, Khadija — University of Michigan at Ann Arbor
- Study coordinator: Shafiq, Khadija
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.